Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ostrand-Rosenberg

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Immunogenetics|January 1, 1987
Resistance to 402AX teratocarcinoma involves immunity to minor histocompatibility antigensS Ostrand-Rosenberg, V Clements
Cancer Research|April 16, 1998
Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccinesB A Pulaski, S Ostrand-Rosenberg
Cellular Immunology|May 1, 1991
Rejection of allogeneic tumor is not determined by host responses to MHC class I molecules and is mediated by CD4-CD8+ T lymphocytes that are not lytic for the tumorG A Cole, S Ostrand-Rosenberg
Current Protocols in Immunology|April 25, 2008
Mouse 4T1 breast tumor modelB A Pulaski, S Ostrand-Rosenberg
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1981
H-2 negative teratocarcinoma cells become H-2 positive when passaged in genetically resistant host miceS Ostrand-Rosenberg, V L Cohan
Cellular Immunology|September 1, 1991
Mouse Hepa-1 tumor is rejected by H-2Db-restricted CTL despite decreased MHC class I antigen expressionM I Nishimura, S Ostrand-Rosenberg
Scanning Electron Microscopy|January 1, 1979
Differential localization of H-2 and teratoma-defined antigens on mouse L cell fibroblastsS Ostrand-Rosenberg, M Edidin, B Wetzel
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1990
Rejection of mouse sarcoma cells after transfection of MHC class II genesS Ostrand-Rosenberg, A Thakur, V Clements
Cellular Immunology|April 1, 1986
402AX teratocarcinoma MHC class I antigen expression is regulated in vivo by Lyt 1, Lyt 2, and L3T4 expressing splenic T cellsS Ostrand-Rosenberg, V Clements, L Marr
Immunogenetics|March 31, 2012
Susceptibility of allogeneic mice to teratocarcinoma 402AXS Ostrand-Rosenberg, T M Rider, A Twarowski
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Immunogenetics|January 1, 1987
Resistance to 402AX teratocarcinoma involves immunity to minor histocompatibility antigensS Ostrand-Rosenberg, V Clements
Cancer Research|April 16, 1998
Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccinesB A Pulaski, S Ostrand-Rosenberg
Cellular Immunology|May 1, 1991
Rejection of allogeneic tumor is not determined by host responses to MHC class I molecules and is mediated by CD4-CD8+ T lymphocytes that are not lytic for the tumorG A Cole, S Ostrand-Rosenberg
Current Protocols in Immunology|April 25, 2008
Mouse 4T1 breast tumor modelB A Pulaski, S Ostrand-Rosenberg
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1981
H-2 negative teratocarcinoma cells become H-2 positive when passaged in genetically resistant host miceS Ostrand-Rosenberg, V L Cohan
Cellular Immunology|September 1, 1991
Mouse Hepa-1 tumor is rejected by H-2Db-restricted CTL despite decreased MHC class I antigen expressionM I Nishimura, S Ostrand-Rosenberg
Scanning Electron Microscopy|January 1, 1979
Differential localization of H-2 and teratoma-defined antigens on mouse L cell fibroblastsS Ostrand-Rosenberg, M Edidin, B Wetzel
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1990
Rejection of mouse sarcoma cells after transfection of MHC class II genesS Ostrand-Rosenberg, A Thakur, V Clements
Cellular Immunology|April 1, 1986
402AX teratocarcinoma MHC class I antigen expression is regulated in vivo by Lyt 1, Lyt 2, and L3T4 expressing splenic T cellsS Ostrand-Rosenberg, V Clements, L Marr
Immunogenetics|March 31, 2012
Susceptibility of allogeneic mice to teratocarcinoma 402AXS Ostrand-Rosenberg, T M Rider, A Twarowski
Pageof 6